Neuroradiology: Page 43

Are brain MRI findings connected to SARS-CoV-2 in spinal fluid?

By Kate Madden Yee

Particular brain MRI findings in some COVID-19 patients are associated with increased likelihood of the presence of the SARS-CoV-2 virus in cerebrospinal fluid, according to a study published June 9 in the Journal of Neuroimaging.

June 8, 2021

FDA approves Alzheimer's treatment under accelerated pathway

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has approved Biogen's aducanumab (Aduhelm) treatment for individuals with Alzheimer's disease. The FDA used an accelerated regulatory pathway for the approval.

June 7, 2021

7T MRI visualizes sickle cell disease's effect on the brain

By AuntMinnie.com staff writers

In a new study, 7-tesla MRI shows the often severe effects that sickle cell disease has on the brain, particularly parts that control learning and memory, according to research published in Neuroimage: Clinical.

June 3, 2021

FieldLine launches HEDscan MEG helmet

By AuntMinnie.com staff writers

Magnetoencephalography (MEG) developer FieldLine has launched HEDscan, a noninvasive whole-head MEG system designed for research of mental health diseases.

June 2, 2021

Using fMRI to plan brain tumor resection boosts patient outcomes

By Kate Madden Yee

The use of preoperative functional MRI (fMRI) to plan brain tumor resection mitigates negative postsurgical outcomes, according to a study published June 1 in Radiology.

June 2, 2021

Darmiyan's BrainSee nabs breakthrough status from FDA

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has granted breakthrough status to Darmiyan's artificial intelligence-based software, BrainSee, which detects Alzheimer's disease from MRI scans.

June 1, 2021

'Early frame' PET may reduce cost and burden in Alzheimer's disease

By Will Morton

PET imaging of patients to detect Alzheimer's disease may be effective in minutes rather than hours after they are injected with a radiotracer, according to research published May 28 in the Journal of Nuclear Medicine. The finding suggests "early frame" PET may reduce imaging costs and burden on patients and their families.

June 1, 2021

Combinostics appoints industry vet Richard Hausmann as CEO

By AuntMinnie.com staff writers

Finnish software developer Combinostics has appointed Richard Hausmann, PhD, as its new CEO, effective June 1.

May 24, 2021

AI enables noninvasive tumor pathology mapping on brain MRI

By Erik L. Ridley

Machine-learning models trained using autopsy tissue samples are revealing new information on brain tumor pathology from MRI exams, according to a May 19 talk at the annual International Society for Magnetic Resonance in Medicine meeting.

May 19, 2021

When are cerebral aneurysm clips 100% safe for MRI exams?

By Philip Ward

In daily practice, it's often not known which type of cerebral aneurysm clip was implanted in a patient, and ferromagnetic-type clips were used until the late 1990s. The Dutch Association of Medical Specialists has now written a guideline for developing a local policy to safely perform MRI in these patients.

May 18, 2021

Macrocyclic gadolinium contrast not to blame for brain deposits

By Amerigo Allegretto

Macrocyclic gadolinium-based contrast agents used in MRI do not cause deposits in the brain and may be useful in glymphatic imaging, according to a presentation by Dr. Alexander Radbruch at the International Society for Magnetic Resonance in Medicine and Society for MR Radiographers & Technologists virtual annual meeting.

May 17, 2021

Up to 40% of COVID-19 survivors experience neurological effects

By Kate Madden Yee

Up to 40% of COVID-19 survivors experience long-term neurological conditions, and it's crucial that radiologists understand these, according to a May 17 presentation at the International Society for Magnetic Resonance in Medicine 2021 virtual annual meeting.

May 17, 2021

Previous Page

Page 43 of 238

Next Page